• Product nameAnti-NARG1 antibody
    See all NARG1 primary antibodies
  • Description
    Rabbit polyclonal to NARG1
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Rat, Zebrafish
  • Immunogen

    Recombinant fragment containing a sequence corresponding to a region within N terminal amino acids 1-282 of Human NARG1 (AAI04807)

  • Positive control
    • 293T cell lysate, A431 cell lysate, Jurkat cell lysate and Raji cell lysate.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.01% Thimerosal (merthiolate)
    Constituents: 20% Glycerol, 0.1M Tris, 0.1M Glycine, pH 7.0
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab104116 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/3000. Predicted molecular weight: 101 kDa.


  • FunctionThe NAA10-NAA15 complex displays alpha (N-terminal) acetyltransferase activity that may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter.
  • Tissue specificityExpressed at high levels in testis and in ocular endothelial cells. Also found in brain (corpus callosum), heart, colon, bone marrow and at lower levels in most adult tissues, including thyroid, liver, pancreas, mammary and salivary glands, lung, ovary, urogenital system and upper gastrointestinal tract. Overexpressed in gastric cancer, in papillary thyroid carcinomas and in a Burkitt lymphoma cell line (Daudi). Specifically suppressed in abnormal proliferating blood vessels in eyes of patients with proliferative diabetic retinopathy.
  • Sequence similaritiesContains 8 TPR repeats.
  • Post-translational
    Cleaved by caspases during apoptosis, resulting in a stable 35 kDa fragment.
  • Cellular localizationCytoplasm. Nucleus. Mainly cytoplasmic, nuclear in some cases. Present in the free cytosolic and cytoskeleton-bound polysomes, but not in the membrane-bound polysomes.
  • Information by UniProt
  • Database links
  • Alternative names
    • 5730450D16Rik antibody
    • 6330400I15 antibody
    • ASTBDN antibody
    • GA19 antibody
    • Gastric cancer antigen Ga19 antibody
    • MGC29428 antibody
    • mNAT1 antibody
    • N alpha acetyltransferase 15, NatA auxiliary subunit antibody
    • N terminal acetyltransferase antibody
    • N(alpha) acetyltransferase 15, NatA auxiliary subunit antibody
    • N-alpha-acetyltransferase 15 antibody
    • N-terminal acetyltransferase antibody
    • Naa15 antibody
    • NAA15_HUMAN antibody
    • NatA auxiliary subunit antibody
    • NATH antibody
    • NMDA receptor regulated 1 antibody
    • NMDA receptor regulated protein 1 antibody
    • NMDA receptor-regulated protein 1 antibody
    • Protein tubedown 1 antibody
    • Protein tubedown-1 antibody
    • Tbdn 1 antibody
    • Tbdn100 antibody
    • Transcriptional coactivator tubedown 100 antibody
    • tubedown-1 antibody
    see all

Anti-NARG1 antibody images

  • Anti-NARG1 antibody (ab104116) at 1/1000 dilution + 293T cell lysate at 30 µg

    Predicted band size : 101 kDa

References for Anti-NARG1 antibody (ab104116)

ab104116 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab104116.
Please use the links above to contact us or submit feedback about this product.